Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn

Phase 1/2 Completed 28 enrolled Sohag University

RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this pilot randomized controlled blinded study is to evaluate the feasibility of using nebulized magnesium sulfate in the treatment of PPHN.

Timeline

Start: 2017-11-01
Primary completion: 2020-07-01
Completion: 2020-08-01

Publications

Abdelkreem E, Mahmoud SM, Aboelez MO, Abd El Aal M. Nebulized Magnesium Sulfate for Treatment of Persistent Pulmonary Hypertension of Newborn: A Pilot Randomized Controlled Trial. Indian J Pediatr. 2021 Aug;88(8):771-777. doi: 10.1007/s12098-020-03643-y. Epub 2021 Jan 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Magnesium Sulfate	Other / unclassified	50 mg/kg	Inhaled
Subject	Magnesium Sulfate	Other / unclassified	256 mg	Inhaled

Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn

Summary

Timeline

Publications

Drugs

Indications